M&A Deal Summary

Kester Capital Acquires Frontier Medical Group

On December 10, 2013, private equity firm Kester Capital acquired medical products company Frontier Medical Group

Acquisition Highlights
  • This is Kester Capital’s 1st transaction in the Medical Products sector.
  • This is Kester Capital’s 3rd transaction in the United Kingdom.
Investment Fate
  • Frontier Medical Group was sold to a consortium of financial buyers in 2021.

M&A Deal Summary
Date 2013-12-10
Target Frontier Medical Group
Sector Medical Products
Buyer(s) Kester Capital
Deal Type Buyout (LBO, MBO, MBI)

Target

Frontier Medical Group

Tredegar, United Kingdom
website
Frontier Medical is a diversified medical devices business focused on the Skin/Wound Care and Infection Prevention markets. The business’ Skin/Wound Care brands include Repose®, Toto® and DermisPlus® which are used in the prevention and treatment of pressure ulcers (bed sores) and treatment of wounds. Frontier Medical Group was founded in 1966 and is based in Tredegar, United Kingdom.

Search 192,907 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Kester Capital

Investor Investor Investor Investor

website

Category Private Equity Firm
Founded 2007
Size Small
Type Sector Agnostic
DESCRIPTION

Kester Capital is a private equity firm focused on middle-market company investments in the UK. The Firm looks to invest a minimum of £5 million in businesses valued up to £100 million. Kester Capital was originally established in 2007 as Greenhill Capital Partners Europe, the European private equity arm of Greenhill & Co Inc. Kester Capital is based in London.

DEAL STATS #
Overall 6 of 13
Sector (Medical Products) 1 of 2
Type (Buyout (LBO, MBO, MBI)) 5 of 10
Country (United Kingdom) 3 of 9
Year (2013) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-12-01 Chiltern International

Bristol, Tennessee, United States

Chiltern International, Inc. is a global contract research organization, and a provider of clinical services and solutions in a variety of therapeutic areas with engagement models for biopharmaceutical and medical device industries. Chiltern’s team of more than 4,500, located across 47 countries, provides comprehensive Clinical Development, Medical & Scientific Affairs, Data & Analysis, Pharmacovigilance and Strategic Regulatory services using a collaborative approach for more efficient clinical trials. Visit Chiltern.com to learn more about how Chiltern is Designed Around You®.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-06-17 Ironshore

Hamilton, Bermuda

Ironshore, Inc. is a provider of broker-sourced specialty property and casualty insurance coverages for varying risks on a global basis through its international platforms.

Sell -
Mergr

Product

Company

Legal